Trial Profile
Phase III trial of tivantinib in patients with c-Met-associated soft tissue sarcoma
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 04 Mar 2010
Price :
$35
*
At a glance
- Drugs Tivantinib (Primary)
- Indications Soft tissue sarcoma
- Focus Registrational; Therapeutic Use
- Sponsors ArQule
- 04 Mar 2010 New trial record